Skip to content
healthcare.dev

AQNEURSA

NDC 83853-101, levacetylleucine, granule, for suspension, from IntraBio Inc.

Product NDC
83853-101
Status
Listed
Labeler
IntraBio Inc
Dosage form
GRANULE, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219132
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83853-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVACETYLLEUCINE1000 mg/1

Pharmacologic classes

Bile Salt Export Pump Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]; Organic Anion Transporter 1 Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
83853-101-018385301010128 PACKET in 1 CARTON (83853-101-01) / 1 GRANULE, FOR SUSPENSION in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0f248e55-d1bb-13f9-e063-6294a90a05ce

Use it

Look up 83853-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83853-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83853-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.